IMC Chicago’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

IMC Chicago’s Portfolio LABD Stock Details LABD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$204K	Buy	+12,486	New	+$236K	﹤0.01%	4994
2024 Q1	–	Sell	-10,513	Closed	-$1.02M	–	2434
2023 Q4	$1.02M	Buy	+10,513	New	+$2.05M	﹤0.01%	1431
2023 Q1	–	Sell	-6,658	Closed	-$1.15M	–	1334
2022 Q4	$1.15M	Buy	+6,658	New	+$1.36M	﹤0.01%	971
2020 Q4	–	Sell	-2,018	Closed	-$1.2M	–	1078
2020 Q3	$1.2M	Buy	+2,018	New	+$1.3M	﹤0.01%	693
2020 Q1	–	Sell	-1,398	Closed	-$3.45M	–	874
2019 Q4	$3.45M	Buy	1,398 +1,177	+533%	+$4.18M	0.01%	411
2019 Q3	$1.12M	Buy	+221	New	+$910K	﹤0.01%	551

Other funds holding LABD

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

CCM

Capstone Capital Management Hong Kong $224M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

IMC Chicago's LABD Position: Q1 2026 in Review

IMC Chicago opened a new position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2026: 12,486 shares worth $204K. The stake represents ﹤0.01% of the portfolio and ranks #4994 among its holdings. This is a return to the name: IMC Chicago previously reported a position in LABD as recently as Q4 2023.

IMC Chicago first reported a position in LABD in Q3 2019 and has held it in 6 quarters since. The position peaked at $3.45M in Q4 2019. 17 funds tracked by Wall St. Rank hold LABD as of Q1 2026.

IMC Chicago held 12,486 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $204K as of Q1 2026.
Direxion Daily S&P Biotech Bear 3X ETF was a new IMC Chicago position in Q1 2026.
Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #4994 holding.
IMC Chicago first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2019 and has held it in 6 quarters since.
IMC Chicago's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $3.45M in Q4 2019.
17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.